I
InfoBionic
InfoBionic's MoMe® Kardia System: Transforming the Efficiency of Arrhythmia Detection and Monitoring Management
About InfoBionic
InfoBionic is a healthcare technology startup that specializes in mobile cardiac telemetry. The company's primary product is the MoMe™ ARC Platform, a remote cardiology monitoring system designed to provide hospital-grade telemetry that can be customized according to the clinical use case and patient needs. This platform is designed to support high acuity hospital-to-home scenarios, providing near real-time, high-fidelity data for remote cardiac monitoring.
InfoBionic's business model is centered on providing healthcare professionals with the tools they need to deliver virtual care. The company's platform allows clinicians to access patient data through a suite of secure, HIPAA compliant solutions for quality, alerting, reporting, and more. This means that doctors and other healthcare professionals can monitor their patients' heart health remotely, reducing the need for in-person visits and potentially catching heart problems earlier.
The company's target market is primarily healthcare providers, including hospitals and clinics, who need to monitor their patients' heart health remotely. InfoBionic makes money by selling its MoMe™ ARC Platform and related services to these healthcare providers.
In addition to its core platform, InfoBionic also plans to offer a suite of virtual telemetry solutions in the future, including advanced connective devices and modular and scalable wireless sensors. These additional products will further enhance the company's ability to provide comprehensive remote cardiac monitoring services.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2011
- Headquarters
- Chelmsford, United States
- Employees
- 21
- Open positions
- None listed
- Dealroom signal
- 76.6/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Biotechnology, Cardiology and cardiovascular, Remote Monitoring, Tech for Patients, Biotech and Pharma, Hard Tech, remote health monitoring, DT and LS, science-based
- Technology
- Hardware
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES DOther financing | Oct 2023 | — | — | Mayo Clinic · Zaffre Investments · Safeguard Scientifics · Excel Venture Management | ↗ |
| LATE VCOther financing | Sep 2018 | $50M | $200M | Excel Venture Management · Zaffre Investments · Safeguard Scientifics | ↗ |
Growth signals
Latest recorded traffic for InfoBionic is 3.8K monthly website visits, up 40.7% over the last three months. InfoBionic's team declined 4.5% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
- FAFort Point Angels
Series A2 investors entered at this stage
Safeguard Scientifics- CACherrystone Angels
Series B and later5 investors entered at this stage
Excel Venture Management
Zaffre Investments
Mayo Clinic
Blue Cross and Blue Shield of Kansas- SISecurity International Investments
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about InfoBionic on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See InfoBionic’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.